Local drug delivery using coated stents: New developments and future perspectives

被引：27

作者：

Tanabe, K ^{[1
]}

Regar, E ^{[1
]}

Lee, CH ^{[1
]}

Hoye, A ^{[1
]}

van der Giessen, WJ ^{[1
]}

Serruys, PW ^{[1
]}

机构：

[1] Erasmus MC, Thoraxctr, NL-3015 GD Rotterdam, Netherlands

来源：

CURRENT PHARMACEUTICAL DESIGN | 2004年 / 10卷 / 04期

关键词：

drugs; stent; restenosis;

D O I：

10.2174/1381612043453289

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Percutaneous coronary intervention has been hampered by restenosis since its inception. Many research projects including the use of various devices and systemic drug administration have shown disappointing results. The clinical data reported from trials with sirolimus- and paclitaxel- eluting stents have been very promising, such that stents with the capability of drug elution are currently attracting the medical community for the prevention of restenosis. Based on the mechanism of action of the drugs released from the stent and the target of the restenotic process, there may be 4 therapeutic objectives: anti-inflammatory, anti-proliferative, anti-migratory, and pro-endothelial healing. There are many candidate agents for drug-eluting stents, however, it now becomes clear that not all drug-eluting stents are equally effective. This article describe candidate agents which have been tested or currently under investigation, and summarize the latest information.

引用

页码：357 / 367

页数：11

共 82 条

[41] Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis - Results of the randomized investigation by the thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial [J].

Kutryk, MJB ;

Foley, DP ;

van den Brand, M ;

Hamburger, JN ;

van der Giessen, WJ ;

deFeyter, PJ ;

Bruining, N ;

Sabate, M ;

Serruys, PW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :281-287

[42] Coronary artery disease obscuring giant cell myocarditis - A case report [J].

Kwok, OH ;

Chau, EMC ;

Wang, EP ;

Chow, WH .

ANGIOLOGY, 2002, 53 (05) :599-603

[43] Direct vascular effects of HMG-CoA reductase inhibitors [J].

Laufs, U ;

Liao, JK .

TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (04) :143-148

[44] First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis - Immediate and long-term clinical and angiographic outcome [J].

Liistro, F ;

Stankovic, G ;

Di Mario, C ;

Takagi, T ;

Chieffo, A ;

Moshiri, S ;

Montorfano, M ;

Carlino, M ;

Briguori, C ;

Pagnotta, P ;

Albiero, R ;

Corvaja, N ;

Colombo, A .

CIRCULATION, 2002, 105 (16) :1883-1886

[45] Late acute thrombosis after paclitaxel eluting stent implantation [J].

Liistro, F ;

Colombo, A .

HEART, 2001, 86 (03) :262-264

[46] The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro [J].

Lövdahl, C ;

Thyberg, J ;

Hultgårdh-Nilsson, A .

JOURNAL OF VASCULAR RESEARCH, 2000, 37 (05) :345-354

[47] RAPAMYCIN-FKBP INHIBITS CELL-CYCLE REGULATORS OF PROLIFERATION IN VASCULAR SMOOTH-MUSCLE CELLS [J].

MARX, SO ;

JAYARAMAN, T ;

GO, LO ;

MARKS, AR .

CIRCULATION RESEARCH, 1995, 76 (03) :412-417

[48] The protective effects of estrogen on the cardiovascular system [J].

Mendelsohn, ME ;

Karas, RH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (23) :1801-1811

[49] Arterial remodeling after coronary angioplasty - A serial intravascular ultrasound study [J].

Mintz, GS ;

Popma, JJ ;

Pichard, AD ;

Kent, KM ;

Satler, LF ;

Wong, SC ;

Hong, MK ;

Kovach, JA ;

Leon, MB .

CIRCULATION, 1996, 94 (01) :35-43

[50]

Mohacsi PJ, 1997, J HEART LUNG TRANSPL, V16, P484

← 1 2 3 4 5 6 7 8 9 →